Jagsonpal Pharmaceuticals, 507789, JAGSNPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,580.66
34.76
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,474.54
1.67%
6.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.48
7.41
4.32

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.77
21.76
8.38

PAT CAGR (%)

10 Years
5 Years
3 Years

32.78
26.54
27.48

P:E (Median)

8 Years
5 Years
3 Years

26.98
34.61
32.82

P:BV (Average)

8 Years
5 Years
3 Years

4.97
5.98
5.98

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.45
23.33
23.37

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 82.23 75.61 8.76% 64.20 58.56 9.63% 72.95 74.03 -1.46% 74.47 74.69 -0.29%
Expenses 64.99 61.40 5.85% 53.04 49.85 6.40% 56.68 58.19 -2.59% 58.03 58.41 -0.65%
EBITDA 17.24 14.21 21.32% 11.16 8.71 28.13% 16.27 15.83 2.78% 16.43 16.28 0.92%
EBIDTM 20.97% 18.80% 17.38% 14.88% 22.30% 21.39% 22.07% 21.80%
Other Income 2.83 2.83 0.00% 3.17 2.77 14.44% 2.98 2.32 28.45% 3.03 1.65 83.64%
Interest 0.25 0.25 0.00% 0.25 0.26 -3.85% 0.26 0.26 0.00% 0.27 0.23 17.39%
Depreciation 2.14 2.35 -8.94% 2.32 2.31 0.43% 2.39 2.41 -0.83% 2.39 2.34 2.14%
PBT 17.68 14.43 22.52% 11.76 8.71 35.02% 14.52 38.67 -62.45% 16.81 15.37 9.37%
Tax 4.49 3.64 23.35% 2.99 2.13 40.38% 3.57 6.68 -46.56% 4.24 3.91 8.44%
PAT 13.19 10.80 22.13% 8.76 6.58 33.13% 10.95 31.99 -65.77% 12.57 11.46 9.69%
PATM 16.04% 14.28% 13.65% 11.24% 15.01% 43.22% 16.89% 15.34%
EPS 2.00 1.64 21.95% 1.33 1.00 33.00% 1.66 4.86 -65.84% 1.91 1.74 9.77%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 293.85 268.72 208.70 236.71 217.58 187.95 158.57 166.83 126.53 143.87 143.49 Net Sales Growth 3.87% 28.76% -11.83% 8.79% 15.76% 18.53% -4.95% 31.85% -12.05% 0.26% Cost Of Goods Sold 106.08 96.43 79.98 92.34 88.96 80.78 56.19 72.85 61.11 58.95 59.13 Gross Profit 187.77 172.28 128.72 144.37 128.62 107.17 102.38 93.98 65.42 84.92 84.36 GP Margin 63.90% 64.11% 61.68% 60.99% 59.11% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% Total Expenditure 232.74 217.65 185.63 202.56 192.56 168.87 150.04 157.49 137.64 138.10 131.68 Power & Fuel Cost - 0.19 0.17 0.29 0.47 0.52 0.76 1.41 1.00 2.12 2.26 % Of Sales - 0.07% 0.08% 0.12% 0.22% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% Employee Cost - 70.93 62.09 65.18 57.67 53.98 50.37 46.61 41.88 40.95 37.84 % Of Sales - 26.40% 29.75% 27.54% 26.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% Manufacturing Exp. - 0.59 0.73 0.52 1.05 0.62 0.51 0.73 0.96 1.34 1.70 % Of Sales - 0.22% 0.35% 0.22% 0.48% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% General & Admin Exp. - 23.83 21.64 22.44 28.47 18.75 23.55 19.03 16.31 16.44 13.61 % Of Sales - 8.87% 10.37% 9.48% 13.08% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% Selling & Distn. Exp. - 24.87 19.16 19.21 13.88 12.99 17.45 13.20 11.25 13.74 12.96 % Of Sales - 9.25% 9.18% 8.12% 6.38% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% Miscellaneous Exp. - 0.79 1.87 2.57 2.05 1.22 1.20 3.66 5.14 4.56 12.96 % Of Sales - 0.29% 0.90% 1.09% 0.94% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% EBITDA 61.10 51.07 23.07 34.15 25.02 19.08 8.53 9.34 -11.11 5.77 11.81 EBITDA Margin 20.79% 19.00% 11.05% 14.43% 11.50% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% Other Income 12.01 8.19 9.28 5.73 3.43 4.39 2.53 1.43 0.46 0.47 0.66 Interest 1.03 0.96 0.81 0.41 0.28 0.51 0.51 0.75 0.66 2.64 5.30 Depreciation 9.24 8.13 1.66 1.21 1.53 1.09 1.13 1.02 0.32 1.99 3.09 PBT 60.77 50.17 29.87 38.27 26.64 21.87 9.41 9.00 -11.63 1.60 4.08 Tax 15.29 14.50 7.41 8.09 7.79 4.81 1.54 1.79 -0.08 2.53 0.82 Tax Rate 25.16% 20.76% 24.81% 23.24% 29.24% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% PAT 45.47 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 PAT before Minority Interest 45.47 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.47% 20.60% 10.76% 11.29% 8.67% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% PAT Growth -25.25% 146.48% -15.94% 41.68% 10.55% 116.77% 9.00% - - 264.92% EPS 6.91 8.41 3.41 4.06 2.87 2.59 1.20 1.10 -1.76 1.80 0.49

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 239.95 187.40 158.89 132.76 121.93 111.03 104.47 98.05 109.91 98.36 Share Capital 13.28 13.22 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 204.71 157.11 137.03 119.66 108.83 97.93 91.37 84.95 96.81 85.27 Non-Current Liabilities 25.98 18.11 8.48 4.49 1.88 3.09 3.12 3.19 3.26 3.61 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 14.61 8.48 1.07 1.26 0.02 0.00 0.00 0.00 0.00 0.00 Current Liabilities 25.90 19.13 35.18 34.14 40.40 34.57 28.19 28.58 29.44 57.31 Trade Payables 9.73 7.60 16.58 18.55 18.05 11.71 11.86 9.09 8.98 9.73 Other Current Liabilities 15.16 10.78 10.60 7.70 10.89 8.16 5.60 6.10 7.12 6.61 Short Term Borrowings 0.00 0.00 0.00 0.00 6.79 6.40 3.79 8.30 7.93 38.49 Short Term Provisions 1.01 0.75 8.01 7.89 4.67 8.30 6.95 5.09 5.41 2.48 Total Liabilities 291.83 224.64 202.55 171.39 164.21 148.69 135.78 129.82 142.61 159.28 Net Block 94.45 9.30 24.28 22.60 25.72 24.44 21.64 21.32 21.59 51.61 Gross Block 103.14 11.59 32.87 58.13 60.12 58.17 55.00 53.66 52.88 90.35 Accumulated Depreciation 8.69 2.29 8.59 35.53 34.40 33.74 33.36 32.34 31.28 38.74 Non Current Assets 130.64 27.86 30.39 55.14 43.73 52.39 38.23 35.20 32.50 58.32 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 1.90 3.95 3.04 0.00 0.00 Non Current Investment 0.00 0.00 1.12 28.86 12.06 11.39 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 17.48 11.75 0.69 1.07 5.66 14.53 12.63 10.84 10.90 6.71 Other Non Current Assets 18.71 6.81 4.29 2.62 0.29 0.13 0.00 0.00 0.00 0.00 Current Assets 161.19 179.60 172.17 116.25 120.48 96.31 97.56 94.61 110.11 100.96 Current Investments 0.00 0.00 0.00 21.81 3.25 0.00 0.00 0.00 0.00 0.00 Inventories 15.20 15.00 20.68 29.74 29.72 29.32 32.69 51.43 47.62 39.84 Sundry Debtors 13.18 10.95 20.87 15.58 12.66 21.45 20.75 25.15 39.41 41.69 Cash & Bank 128.73 147.93 114.63 25.25 60.23 40.49 38.53 14.51 20.06 15.53 Other Current Assets 4.08 1.60 1.15 1.41 14.61 5.04 5.58 3.51 3.03 3.90 Short Term Loans & Adv. 2.42 4.12 14.85 22.47 14.34 4.52 4.64 3.27 2.80 3.90 Net Current Assets 135.29 160.47 136.99 82.11 80.08 61.74 69.37 66.03 80.68 43.65 Total Assets 291.83 207.46 202.56 171.39 164.21 148.70 135.79 129.81 142.61 159.28

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 55.30 35.17 46.66 6.91 28.22 11.89 30.90 -1.58 -3.24 9.04 PBT 69.86 29.87 34.81 26.64 21.87 9.41 9.00 -11.63 14.40 4.08 Adjustment -11.94 8.27 9.63 -1.40 -2.09 -0.57 0.33 1.26 -8.63 7.73 Changes in Working Capital 5.52 5.54 9.50 -11.46 11.59 4.84 19.71 8.79 -6.13 -1.96 Cash after chg. in Working capital 63.44 43.68 53.93 13.79 31.37 13.69 29.05 -1.58 -0.36 9.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.14 -8.51 -7.28 -6.87 -3.15 -1.80 1.85 0.00 -2.88 -0.82 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -45.15 -24.55 -57.67 -25.78 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 Net Fixed Assets -91.55 21.28 25.26 1.99 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 Net Investments 0.00 1.12 49.55 -35.36 -3.92 -11.39 0.00 0.00 0.00 0.00 Others 46.40 -46.95 -132.48 7.59 1.71 1.44 1.42 0.45 3.82 0.65 Cash from Financing Activity -11.70 -8.91 -0.46 -17.55 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 Net Cash Inflow / Outflow -1.54 1.71 -11.47 -36.42 19.13 -1.01 24.02 -5.55 4.53 0.52 Opening Cash & Equivalents 12.76 11.05 22.53 58.94 39.81 40.82 14.51 20.06 15.53 15.02 Closing Cash & Equivalent 11.21 12.76 11.05 22.53 58.94 39.81 38.53 14.51 20.06 15.53

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 32.83 25.77 57.30 50.68 43.55 39.39 36.89 34.43 38.96 34.55 ROA 21.44% 10.52% 14.29% 11.24% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% ROE 28.51% 14.02% 18.89% 15.28% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% ROCE 33.14% 17.72% 24.15% 21.23% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% Fixed Asset Turnover 4.91 10.09 5.65 4.10 3.18 2.80 3.07 2.38 2.03 1.62 Receivable days 15.63 25.88 25.87 21.26 33.13 48.57 50.22 93.07 102.03 109.58 Inventory Days 19.56 29.02 35.78 44.76 57.34 71.38 92.03 142.78 110.02 92.27 Payable days 32.80 55.17 69.43 75.08 67.24 34.46 31.91 27.07 22.17 21.36 Cash Conversion Cycle 2.39 -0.27 -7.78 -9.07 23.23 85.49 110.33 208.78 189.88 180.49 Total Debt/Equity 0.00 0.00 0.00 0.00 0.06 0.06 0.04 0.09 0.08 0.43 Interest Cover 73.92 37.69 85.28 94.48 43.59 19.31 13.08 -16.69 6.44 1.77

Top Investors:

manish gupta

investor education and protection fund authority ministry of corporate affairs

authum investment and infrastructure limited

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
30th Jul 2026, 00:00 AM

Read More
Jagsonpal Pharmaceuticals completes acquisition of 69.77% stake in Aequitas Healthcare
7th Jul 2026, 16:26 PM

Consequently, Aequitas has become a subsidiary of the Jagsonpal Pharmaceuticals
Read More
Jagsonpal Pharma inks definitive pact to acquire 85% equity stake in Aequitas
29th Jun 2026, 18:25 PM

The total consideration for 85% stake would be Rs 20.8 crore, which shall be funded from internal accruals of the company
Read More

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: